Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
25.61
+0.04 (0.16%)
Jun 29, 2026, 12:51 PM EDT - Market open
Denali Therapeutics Employees
Denali Therapeutics had 503 employees as of December 31, 2025. The number of employees increased by 81 or 19.19% compared to the previous year.
Employees
503
Change (1Y)
81
Growth (1Y)
19.19%
Revenue / Employee
n/a
Profits / Employee
-$1,002,006
Market Cap
4.06B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 154 |
| Parabilis Medicines | 145 |
DNLI News
- 11 days ago - Denali Therapeutics enters agreement to sell Rare Pediatric Disease PRV - TheFly
- 11 days ago - Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million - GlobeNewsWire
- 19 days ago - Denali Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Denali Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Denali Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Denali Therapeutics price target lowered to $35 from $40 at Morgan Stanley - TheFly
- 5 weeks ago - Denali Therapeutics price target lowered to $31 from $35 at Deutsche Bank - TheFly
- 5 weeks ago - Denali Therapeutics trading resumes - TheFly